본문으로 건너뛰기
← 뒤로

The role of cardiac imaging for diagnosis of cardiac amyloidosis: a systematic review and meta-analysis of test accuracy.

메타분석 1/5 보강
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2026 Vol.33(1) p. 59-71
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: biopsy proven light-chain (AL) amyloidosis
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Certainty of evidence was very low. [CONCLUSION] CMR might be more accurate than echocardiography for diagnosis of cardiac involvement in AL amyloidosis.

Kawtharany H, Azzam M, Nazzal J, Hamarsha Q, Alkhader A, Khraise T, M AlMasri M, K Abou Zeid H, Alwan I, Alzabibi MA, Jaber N, Jamal F, Dasgupta N, Sarswat N, H De La Torre A, Aguirre MA, Boedicker D, Bumma N, Carroll AS, Comenzo R, Cook J, Dispenzieri A, Khouri J, Picken MM, Raza S, Leung N, Sanchorawala V, Shaikh H, Singh D, D Seftel M, Kukreti V, Mustafa RA

📝 환자 설명용 한 줄

[OBJECTIVE] To evaluate the diagnostic test accuracy of cardiac magnetic resonance (CMR) and echocardiography for diagnosis of cardiac involvement in patients with biopsy proven light-chain (AL) amylo

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • Specificity 95%
  • 연구 설계 systematic review

이 논문을 인용하기

↓ .bib ↓ .ris
APA Kawtharany H, Azzam M, et al. (2026). The role of cardiac imaging for diagnosis of cardiac amyloidosis: a systematic review and meta-analysis of test accuracy.. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 33(1), 59-71. https://doi.org/10.1080/13506129.2025.2596145
MLA Kawtharany H, et al.. "The role of cardiac imaging for diagnosis of cardiac amyloidosis: a systematic review and meta-analysis of test accuracy.." Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, vol. 33, no. 1, 2026, pp. 59-71.
PMID 41479129 ↗

Abstract

[OBJECTIVE] To evaluate the diagnostic test accuracy of cardiac magnetic resonance (CMR) and echocardiography for diagnosis of cardiac involvement in patients with biopsy proven light-chain (AL) amyloidosis.

[METHODS] This systematic review addresses late gadolinium enhancement (LGE) on CMR and different echocardiographic findings for cardiac involvement using an acceptable reference standard. Meta-analysis reported sensitivity and specificity with 95% confidence intervals when we have ≥3 studies, or ranges for 2 studies. We assessed certainty of evidence using GRADE (Grading of Recommendations Assessment, Development, and Evaluation).

[RESULTS] Seven studies evaluated LGE, yielding pooled sensitivity and specificity of 0.95 (0.87-0.98) and 0.87 (0.76-0.94). Nineteen studies addressed echocardiography. Interventricular septum thickness showed sensitivity of 0.77 (0.69-0.84) and specificity of 0.71 (0.60-0.81). Diastolic dysfunction (grade 2-3) sensitivity was 0.71 (0.40-0.90) and specificity was 0.75 (0.64-0.84); restrictive filling pattern (grade 3) sensitivity was 0.42 (0.28-0.58) and specificity 0.89 (0.83-0.94). E/A ratio sensitivity ranged from 0.45 to 0.65, with specificity from 0.85 to 0.98. Global longitudinal strain sensitivity was 0.86 (0.65-0.95) and specificity was 0.76 (0.55-0.89). Apical sparing pattern showed sensitivity of 0.72 (0.64-0.78) and specificity of 0.78 (0.64-0.88). Certainty of evidence was very low.

[CONCLUSION] CMR might be more accurate than echocardiography for diagnosis of cardiac involvement in AL amyloidosis.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반